Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Darbepoetin alfa (25mcg) Injection
Therapeutic Category
Urology
Dosage Form
Injection
Packaging Type
Pre-Filled Syringe
Packaging
25mcg
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Darbepoetin Alfa 25mcg injection is an erythropoiesis-stimulating agent (ESA) used for managing anemia associated with chronic kidney disease and chemotherapy-induced anemia.
It works by stimulating the bone marrow to produce more red blood cells, helping improve hemoglobin levels and oxygen-carrying capacity in patients suffering from anemia.
This injection is widely prescribed in chronic kidney disease management, dialysis patient care, and oncology-related anemia treatment, supporting improved energy levels and overall patient well-being.
With strong clinical relevance in nephrology and oncology care, high hospital demand, and essential role in anemia management protocols, this formulation strengthens institutional therapy portfolios and supports consistent therapeutic utilization.
Some patients may experience increased blood pressure, headache, injection site discomfort, nausea, or fatigue. In rare cases, allergic reactions, blood clots, or severe hypertension may occur and require immediate medical attention.
Darbot 25 Injection is indicated for the treatment of anemia associated with chronic kidney disease, including patients undergoing dialysis and those not on dialysis. It is also used to manage anemia in patients receiving chemotherapy for certain types of cancer.
This injection should be administered under the supervision of a qualified healthcare professional. Regular monitoring of hemoglobin levels and blood pressure is recommended during treatment. The dosage should be adjusted based on the patient’s clinical response and medical advice.
Store in a refrigerator at 2°C–8°C. Do not freeze. Protect from light and keep the injection in its original packaging. Keep out of reach of children.
Composition : Ursodeoxycholic Acid (150mg)
Composition : Ursodeoxycholic Acid (300mg)
Composition : Ursodeoxycholic Acid (450mg) SR
Composition : Ursodeoxycholic Acid (125mg/5ml)
Composition : Sodium Bicarbonate (500mg)
Composition : Sodium Bicarbonate (1000mg)
Composition : Obeticholic acid (5mg) Tablet
Composition : Obeticholic acid (10mg) Tablet
Composition : Rabeprazole (20mg)
Composition : Lansoprazole (30mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Darbepoetin Alfa 25mcg Injection has strong demand in the nephrology and hospital critical care segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in anemia management, especially in chronic kidney disease (CKD), dialysis patients, and oncology supportive care. It strengthens their hospital injectable portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Darbepoetin Alfa 25mcg Injection with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady hospital demand, long-term chronic therapy usage, and strong institutional sales opportunities when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this nephrology/hematology injection can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.